Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer

被引：0
|
作者：
Rossanna C. Pezo
Tom W. Chen
Hal K. Berman
Anna M. Mulligan
Albiruni A. Razak
Lillian L. Siu
David W. Cescon
Eitan Amir
Christine Elser
David G. Warr
Srikala S. Sridhar
Celeste Yu
Lisa Wang
Tracy L. Stockley
Suzanne Kamel-Reid
Philippe L. Bedard
机构：
[1] Princess Margaret Cancer Centre,Division of Medical Oncology and Hematology
[2] University of Toronto,Department of Medicine
[3] National Taiwan University Hospital,Department of Oncology
[4] University Health Network,Laboratory Medicine Program
[5] University of Toronto,Department of Laboratory Medicine and Pathobiology
[6] Princess Margaret Cancer Centre,Cancer Genomics Program
[7] Princess Margaret Cancer Centre,Department of Biostatistics
[8] University of Toronto,Department of Medical Biophysics
[9] Sunnybrook Odette Cancer Centre,Division of Medical Oncology and Hematology
来源：
Breast Cancer Research and Treatment | 2018年 / 168卷
关键词：
Molecular profiling; Metastatic breast cancer; Targeted therapies; mutation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：159 / 168
页数：9
相关论文
共 50 条
  • [31] The role of multi-gene hereditary cancer panels in male patients with breast cancer
    Postula, Kristen J. Vogel
    Andolina, Laura M.
    Theobald, Kristin
    McGill, Anna K.
    Sutcliffe, Erin
    Arvai, Kevin J.
    Murphy, Patricia D.
    Klein, Rachel T.
    Hruska, Kathleen S.
    CANCER RESEARCH, 2018, 78 (04)
  • [32] The impact of genomic mutation on metastatic breast cancer treatment: A retrospective clinical trial
    Yuan, Y.
    Yost, S.
    Yuan, Y-C
    Liu, Z.
    Frankel, P.
    Nicola, S.
    Mortimer, J.
    CANCER RESEARCH, 2017, 77
  • [33] Germline mutational landscape in 5422 individuals at risk for hereditary breast and ovarian cancer who underwent multi-gene panel testing
    Punie, Kevin
    Hoste, Griet
    Van Buggenhout, Griet
    Denayer, Ellen
    Brems, Hilde
    Peeters, Hilde
    Smeets, Ann
    Nevelsteen, Ines
    Neven, Patrick
    Ardui, Jan
    Prevos, Renate
    Keupers, Machteld
    Van Ongeval, Chantal
    Floris, Giuseppe
    Desmedt, Christine
    Wildiers, Hans
    Michils, Genevieve
    Van Esch, Hilde
    Legius, Eric
    CANCER RESEARCH, 2020, 80 (04)
  • [34] Inflammatory Breast Cancer: Clinical Implications of Genomic Alterations and Mutational Profiling
    Faldoni, Flavia L. C.
    Villacis, Rolando A. R.
    Canto, Luisa M.
    Fonseca-Alves, Carlos E.
    Cury, Sarah S.
    Larsen, Simon J.
    Aagaard, Mads M.
    Souza, Cristiano P.
    Scapulatempo-Neto, Cristovam
    Osorio, Cynthia A. B. T.
    Baumbach, Jan
    Marchi, Fabio A.
    Rogatto, Silvia R.
    CANCERS, 2020, 12 (10) : 1 - 21
  • [35] Breast cancer subtype classification using a multi-gene expression profile
    Ravaioli, Sara
    Pirini, Francesca
    Rocca, Andrea
    Puccetti, Maurizio
    Bonafe, Massimiliano
    Martinelli, Giovanni
    Bravaccini, Sara
    CANCER RESEARCH, 2019, 79 (13)
  • [36] A multi-gene panel study in hereditary breast and ovarian cancer in Colombia
    Cock-Rada, A. M.
    Ossa, C. A.
    Garcia, H. I.
    Gomez, L. R.
    FAMILIAL CANCER, 2018, 17 (01) : 23 - 30
  • [37] A multi-gene panel study in hereditary breast and ovarian cancer in Colombia
    A. M. Cock-Rada
    C. A. Ossa
    H. I. Garcia
    L. R. Gomez
    Familial Cancer, 2018, 17 : 23 - 30
  • [38] Multi-gene fluorescence in situ hybridization analysis of cell cycle gene copy number aberrations in breast cancer with metastatic lymph nodes
    Zhang, S.
    Li, J.
    Su, W.
    Hu, Y.
    Liu, J.
    Zhang, X.
    Bai, J.
    Yuan, W.
    Hu, L.
    Cheng, T.
    Anders, Z.
    Zhang, J.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S274 - S274
  • [39] Normalized quantitative multi-gene expression analysis of Circulating Tumor Cells (CTC) in primary and metastatic breast cancer patients
    Fersis, N.
    Koliogiannis, D.
    Sisic, L.
    Sohn, C.
    Kaul, S.
    ONKOLOGIE, 2008, 31 : 26 - 27
  • [40] ESR1 mutational landscape and impact of co-existing resistance variants on clinical outcomes in patients with metastatic breast cancer.
    Medford, Arielle J.
    Leshchiner, Ignaty
    Cha, Justin
    Kiedrowski, Lesli Ann
    Niemierko, Andrzej
    Keenan, Jennifer C.
    Wander, Seth Andrew
    Spring, Laura
    Vidula, Neelima
    Dai, Charles Sichao
    Isakoff, Steven J.
    Gerratana, Lorenzo
    Shah, Ami N.
    Davis, Andrew A.
    Cristofanilli, Massimo
    Moy, Beverly
    Ellisen, Leif W.
    Getz, Gad
    Bardia, Aditya
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345